Cost-effectiveness of moderate-to-severe psoriasis biologic treatments in Brazilian private healthcare system: cost-per-responder results derived from a network metanalysis
J. bras. econ. saúde (Impr.); 12 (3), 2020
Objective: To assess the cost-per-responder (CpR) of biologic therapies available in Brazil to
treat moderate-to-severe plaque psoriasis (PsO) from the private healthcare system’s perspective.
Methods: Number needed to treat (NNT) and (CpR) analyses were performed to evaluate biologic
therapies’ cost...
